193 related articles for article (PubMed ID: 25756509)
1. MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.
Peng X; Cao P; Li J; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Cancer Biol Ther; 2015; 16(2):261-7. PubMed ID: 25756509
[TBL] [Abstract][Full Text] [Related]
2. MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo.
Peng X; Cao P; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Int J Clin Exp Pathol; 2014; 7(10):6784-91. PubMed ID: 25400759
[TBL] [Abstract][Full Text] [Related]
3. Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p.
Wang X; Wang K; Xiao J; Song Y; Li H
Biochem Biophys Res Commun; 2020 Oct; 531(4):573-580. PubMed ID: 32811645
[TBL] [Abstract][Full Text] [Related]
4. Amplification of chromosome 8q21-qter associated with the acquired paclitaxel resistance of nasopharyngeal carcinoma cells.
Li W; You Y; Zhang X; Song Y; Xiang H; Peng X; Qin J; Tan G
Int J Clin Exp Pathol; 2015; 8(10):12346-56. PubMed ID: 26722421
[TBL] [Abstract][Full Text] [Related]
5. Targeted regulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1.
Gao J; Shao Z; Yan M; Fu T; Zhang L; Yan Y
Cancer Biomark; 2018; 22(4):641-648. PubMed ID: 29914005
[TBL] [Abstract][Full Text] [Related]
6. Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance.
Zhang X; Li W; Li H; Ma Y; He G; Tan G
Anticancer Drugs; 2012 Sep; 23(8):856-64. PubMed ID: 22824824
[TBL] [Abstract][Full Text] [Related]
7. miR-29c regulates resistance to paclitaxel in nasopharyngeal cancer by targeting ITGB1.
Huang L; Hu C; Chao H; Wang R; Lu H; Li H; Chen H
Exp Cell Res; 2019 May; 378(1):1-10. PubMed ID: 30779921
[TBL] [Abstract][Full Text] [Related]
8. [Differential expression of taxol resistance and taxol resistance reversal related genes in nasopharyngeal carcinoma by cDNA microarray].
Peng X; Tan G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):48-52. PubMed ID: 22349379
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2).
Liu Y; Gao S; Chen X; Liu M; Mao C; Fang X
Tumour Biol; 2016 Sep; 37(9):12231-12239. PubMed ID: 27236538
[TBL] [Abstract][Full Text] [Related]
10. Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.
Lin X; Yu T; Zhang L; Chen S; Chen X; Liao Y; Long D; Shen F
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):611-620. PubMed ID: 27289016
[TBL] [Abstract][Full Text] [Related]
11. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.
Gan CZ; Li G; Luo QS; Li HM
IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895
[TBL] [Abstract][Full Text] [Related]
12. miR-150 contributes to the radioresistance in nasopharyngeal carcinoma cells by targeting glycogen synthase kinase-3β.
Huang Y; Tan D; Xiao J; Li Q; Zhang X; Luo Z
J Cancer Res Ther; 2018 Jan; 14(1):111-118. PubMed ID: 29516971
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of taxol-resistant nasopharyngeal carcinoma cells with siRNA-mediated FOLR1 downregulation.
Song Y; Peng X; Wang M; Xie J; Tan G
Int J Clin Exp Pathol; 2015; 8(9):11314-22. PubMed ID: 26617855
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-β1/mTOR axis and HOXC6 in nasopharyngeal carcinoma.
Cheng JZ; Chen JJ; Wang ZG; Yu D
Cancer Biomark; 2018; 23(1):107-123. PubMed ID: 29991129
[TBL] [Abstract][Full Text] [Related]
15. Next generation deep sequencing identified a novel lncRNA n375709 associated with paclitaxel resistance in nasopharyngeal carcinoma.
Ren S; Li G; Liu C; Cai T; Su Z; Wei M; She L; Tian Y; Qiu Y; Zhang X; Liu Y; Wang Y
Oncol Rep; 2016 Oct; 36(4):1861-7. PubMed ID: 27498905
[TBL] [Abstract][Full Text] [Related]
16. Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression.
Peng X; Li W; Tan G
Anticancer Drugs; 2010 Apr; 21(4):381-8. PubMed ID: 20051827
[TBL] [Abstract][Full Text] [Related]
17. [Role of folate receptor 1 in paclitaxel-resistance of nasopharyngeal carcinoma cells].
Li W; Tan GL; Ma YH; Peng XW; He GX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Dec; 45(12):1035-40. PubMed ID: 21215055
[TBL] [Abstract][Full Text] [Related]
18. Exosomes derived from Taxol-resistant nasopharyngeal carcinoma (NPC) cells transferred DDX53 to NPC cells and promoted cancer resistance to Taxol.
Yuan F; Zhou ZF
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):127-138. PubMed ID: 33506900
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis.
Wang Q; Zhang W; Hao S
Cell Cycle; 2017 Apr; 16(8):795-801. PubMed ID: 28358263
[TBL] [Abstract][Full Text] [Related]
20. MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.
Yang W; Lan X; Li D; Li T; Lu S
BMC Cancer; 2015 Jun; 15():461. PubMed ID: 26055874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
